Abbott Labs to sell part of generics business for $5.3 billion
July 14, 2014 at 07:34 AM EDT
Abbott Laboratories sells its developed markets branded generics pharmaceuticals business to Mylan in a $5.3 billion deal that includes the formation of a new publicly traded company.